DURHAM, N.C. and SAN FRANCISCO, April 27, 2023 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ ...
DURHAM, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company, today announced that the Company has achieved two milestone payments in its ...
SAN DIEGO & BERLIN & DURHAM, N.C.--(BUSINESS WIRE)--Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results